Inmune Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Inmune Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q4 2024.
- Inmune Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$9.22M, a 9.63% decline year-over-year.
- Inmune Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$42.1M, a 40.2% decline year-over-year.
- Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$42.1M, a 40.2% decline from 2023.
- Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30M, a 9.92% decline from 2022.
- Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$27.3M, a 10% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)